These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3147656)

  • 1. Monoclonal antibody OKT3 in cardiac and renal transplantation.
    Norman DJ
    Bibl Cardiol; 1988; (43):27-32. PubMed ID: 3147656
    [No Abstract]   [Full Text] [Related]  

  • 2. Orthoclone OKT3 monoclonal antibody reversal of hepatic and cardiac allograft rejection unresponsive to conventional immunosuppressive treatments.
    Kremer AB; Barnes L; Hirsch RL; Goldstein G
    Transplant Proc; 1987 Apr; 19(2 Suppl 1):54-7. PubMed ID: 3105141
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison between prophylactic use of OKT3 and cyclosporine in cadaveric renal transplantation.
    De Pauw L; Abramowicz D; Goldman M; Vereerstraeten P; Kinnaert P; Toussaint C
    Transplant Proc; 1990 Aug; 22(4):1759-60. PubMed ID: 2117800
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of Orthoclone OKT3 monoclonal antibody to reverse acute renal allograft rejection unresponsive to treatment with conventional immunosuppressive regimens.
    Monaco A; Goldstein G; Barnes L
    Transplant Proc; 1987 Apr; 19(2 Suppl 1):28-31. PubMed ID: 3105137
    [No Abstract]   [Full Text] [Related]  

  • 5. A U.S. clinical study of Orthoclone OKT3 in renal transplantation.
    Norman DJ; Shield CF; Barry J; Henell K; Funnell MB; Lemon J
    Transplant Proc; 1987 Apr; 19(2 Suppl 1):21-7. PubMed ID: 3105136
    [No Abstract]   [Full Text] [Related]  

  • 6. Overview of the development of Orthoclone OKT3: monoclonal antibody for therapeutic use in transplantation.
    Goldstein G
    Transplant Proc; 1987 Apr; 19(2 Suppl 1):1-6. PubMed ID: 3105134
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of Orthoclone OKT3 monoclonal antibody in cardiac transplantation: early experience with rejection prophylaxis and treatment of refractory rejection.
    Gilbert EM; Eiswirth CC; Renlund DG; Menlove RL; DeWitt CW; Freedman LA; Herrick CM; Gay WA; Bristow MR
    Transplant Proc; 1987 Apr; 19(2 Suppl 1):45-53. PubMed ID: 3105140
    [No Abstract]   [Full Text] [Related]  

  • 8. Fibrinoid necrosis of a temporal artery complicating the treatment of refractory cardiac allograft rejection with murine monoclonal CD3 antibody (OKT3).
    Hammond EH; Watson FS; Bristow MR; O'Connell JB; Gilbert EM; Doty DB; Renlund DG
    J Heart Transplant; 1990; 9(3 Pt 1):236-8. PubMed ID: 2113090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical development of Orthoclone OKT3.
    Cosimi AB
    Transplant Proc; 1987 Apr; 19(2 Suppl 1):7-16. PubMed ID: 3105142
    [No Abstract]   [Full Text] [Related]  

  • 10. Reversing cardiac transplant rejection with Orthoclone OKT3.
    Dault LA; Nagy CS; Collins JA
    Am J Nurs; 1989 Jul; 89(7):953-5. PubMed ID: 2500020
    [No Abstract]   [Full Text] [Related]  

  • 11. Induction immunosuppression with OKT3 monoclonal antibody in cardiac transplant recipients.
    Pulpón LA; Domínguez P; Cháfer M; Segovia J; Crespo MG; Pradas G; Burgos R; Figuera D
    Transplant Proc; 1990 Oct; 22(5):2319. PubMed ID: 2120816
    [No Abstract]   [Full Text] [Related]  

  • 12. Orthoclone OKT3 as rescue treatment for steroid-resistant and recurrent acute rejection in clinical renal transplantation.
    Tvedegaard E; Olgaard K
    Transplant Proc; 1990 Feb; 22(1):217-8. PubMed ID: 2106738
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute renal allograft rejection: the role of monoclonal antibodies in treatment: experience with orthoclonal anti-T3 cell antibody.
    McLigeyo SO; Notghi A; Anderton JL; Dick J
    East Afr Med J; 1990 Sep; 67(9):667-73. PubMed ID: 2123786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First and second course of OKT3 monoclonal anti-T cell antibody for treatment of renal allograft rejection followed by testing for anti-OKT3 IgM and/or IgG immunization.
    Birkeland SA; Bach JF; Chatenoud L; Jørgensen KA; Strate M; Elbirk A; Rohr N; Svendsen V
    Transplant Proc; 1990 Feb; 22(1):221-2. PubMed ID: 2106740
    [No Abstract]   [Full Text] [Related]  

  • 15. Antimurine antibody to OKT3 in cardiac transplantation: implications for prophylaxis and retreatment of rejection.
    O'Connell JB; Bristow MR; Hammond EH; Menlove RL; Ensley RD; Ratkovec RM; Renlund DG
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1157-9. PubMed ID: 1899154
    [No Abstract]   [Full Text] [Related]  

  • 16. Orthoclone OKT3 as first-line therapy in acute renal allograft rejection.
    Strate M; Jørgensen KA; Rohr N; Elbirk A; Svendsen V; Birkeland SA
    Transplant Proc; 1990 Feb; 22(1):219-20. PubMed ID: 2106739
    [No Abstract]   [Full Text] [Related]  

  • 17. The prophylactic use of Orthoclone OKT3 in kidney and heart transplantation.
    Weimar W; Baumgartner D; Hendriks GF; Hesse CJ; Balk AH; Simoons ML; Bos E
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):96-100. PubMed ID: 3140455
    [No Abstract]   [Full Text] [Related]  

  • 18. OKT3 in severe early rejection: predictors for reversal in renal transplant recipients.
    Sumrani N; Delaney V; Rajpoot D; Tejani A; Butt K; Hong J
    Transplant Proc; 1990 Aug; 22(4):1750-2. PubMed ID: 2117797
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiac allograft cellular rejection during OKT3 prophylaxis in the absence of sensitization.
    Moore CK; O'Connell JB; Renlund DG; Bristow MR; Hammond EH
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1055-8. PubMed ID: 1899151
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapy of refractory, recurrent heart rejection with multiple courses of OKT3.
    Frist WH; Gerhardt EB; Merrill WH; Atkinson JB; Eastburn TE; Stewart JR; Hammon JW; Bender HW
    J Heart Transplant; 1990; 9(6):724-6. PubMed ID: 2126035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.